October 14, 2003Open Access

Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing β-Blocker Therapy

Structured PICO

Does gadolinium-enhanced CMR predict the response in LV function and remodeling in heart failure patients treated with beta-blockers?

Population

Heart failure patients treated with beta-blockers

Intervention

Gadolinium-enhanced Cardiovascular Magnetic Resonance (CMR)

Outcome

Response in LV function and remodelingsurrogate

Gadolinium-enhanced CMR can serve as a predictive tool for assessing potential improvements in LV function and remodeling in heart failure patients initiating beta-blocker therapy.

Abstract

For heart failure patients treated with beta-blockers, gadolinium-enhanced CMR predicts the response in LV function and remodeling.

Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing β-Blocker Therapy

Structured PICO

Abstract

Cite This Study